0 items USD 0.00Search
- Did you mean
- crown diseases
Your search for "crohn diseases" gave back 37044 results.
The global Crohn's Disease Treatment Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2025
Price: USD 3,660.00
The global Crohn's Disease market size was valued at US$ 8467.1 million in 2023. With growing demand in downstream market, the Crohn's...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
November 2024
Price: USD 3,660.00
The global Crohn’s Disease Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Crohn’s Disease Drug is...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
December 2024
Price: USD 3,660.00
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
The global Crohn’s Disease Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
December 2024
Price: USD 3,480.00
The global IBD (Ulcerative Colitis and Crohn's Disease) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
The global Certolizumab Pegol market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
December 2024
Price: USD 3,480.00
The global Humira market size is predicted to grow from US$ 13010 million in 2025 to US$ 7580 million in 2031; it is expected to grow at a CAGR of -8...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
July 2025
Price: USD 3,660.00
The global market for Humira was valued at US$ 14370 million in the year 2024 and is projected to reach a revised size of US$ 7907 million by 2031,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2025
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
November 2024
Price: USD 3,950.00
The global Inflammatory Bowel Disease market size was valued at US$ 12530 million in 2023. With growing demand in downstream market, the Inflammatory...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
December 2024
Price: USD 3,660.00
The global Humira market size was valued at US$ 15980 million in 2024 and is forecast to a readjusted size of USD 8906 million by 2031 with a CAGR of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
February 2025
Price: USD 3,480.00
Rectal mesalazine, also known as rectal 5-aminosalicylic acid (5-ASA) or rectal mesalamine, is a medication used to treat certain inflammatory bowel...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
October 2024
Price: USD 3,950.00
The global Inflammatory Bowel Disease market size was valued at USD 13170 million in 2023 and is forecast to a readjusted size of USD 16590 million...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
November 2024
Price: USD 3,480.00
Ìý
Filter By Report Date
- (-) Remove Past year filter Past year
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
